More Press Releases

View Older Stories View Newer Stories

Jun 3, 2024 07:00AM RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040
Jun 3, 2024 07:00AM Marriott International Announces Three Conversions to Bring Iconic Luxury Properties in the United States into the Marriott Bonvoy Portfolio Later This Summer
Jun 3, 2024 07:00AM PawFury's Presale Raises Over $3 Million, Set To Surpass Pepe and SHIB
Jun 3, 2024 07:00AM Coalesce Capital Announces Key Hires as Firm Continues to Expand Leadership Team
Jun 3, 2024 07:00AM Dominion Energy Announces Closing of Sale of Western Natural Gas Distribution Assets Questar Gas, Wexpro
Jun 3, 2024 07:00AM FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3, 2024 07:00AM PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
Jun 3, 2024 07:00AM Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
Jun 3, 2024 07:00AM Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
Jun 3, 2024 07:00AM At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
Jun 3, 2024 07:00AM ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
Jun 3, 2024 07:00AM Recurrent Energy Announces Initial Closing of Investment from BlackRock
Jun 3, 2024 07:00AM Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
Jun 3, 2024 07:00AM Osisko Development to Complete Second Deferred Payment Installment in Connection With the Tintic Acquisition
Jun 3, 2024 07:00AM Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Jun 3, 2024 07:00AM Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
Jun 3, 2024 07:00AM Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology
Jun 3, 2024 07:00AM Pershing Square Holdings, Ltd. Notes the Sale by Pershing Square Capital Management, L.P. of a 10% Common Equity Interest to Strategic Investors
Jun 3, 2024 07:00AM Skye Bioscience to Present at Jefferies Global Healthcare Conference
Jun 3, 2024 07:00AM StateServ Rebrands to Dragonfly Health
Jun 3, 2024 07:00AM EagleRider Motorcycle Rental and Tours Announces New CEO Sebastian Schoepe
Jun 3, 2024 07:00AM Enbridge Completes Acquisition of Questar Gas Company
Jun 3, 2024 07:00AM Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
Jun 3, 2024 07:00AM Flow Beverage Corp. to Release Second Quarter 2024 Financial Results
Jun 3, 2024 07:00AM Consor Holdings Announces Growth Investment from New Mountain Capital
Jun 3, 2024 07:00AM Graphite One Announces Repricing of Stock Options
Jun 3, 2024 07:00AM International Energy Forum Report Details EV Copper Hurdles
Jun 3, 2024 07:00AM Dunes Point Capital, LP Announces Roofing Services Solutions' Acquisition of West Orange Roofing, LLC
Jun 3, 2024 07:00AM Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
Jun 3, 2024 07:00AM Lithium Drilling Program Commences at East Vallée
Jun 3, 2024 07:00AM Gryphon Investors-Backed Thermal Technology Distribution Solutions Acquires Southwest Heater and Controls
Jun 3, 2024 07:00AM Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
Jun 3, 2024 07:00AM Catona Climate to Offer High-Quality Carbon Credits through Integration with GreenLight Solution by Deloitte
Jun 3, 2024 07:00AM Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Jun 3, 2024 07:00AM Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
Jun 3, 2024 07:00AM Andreas Nix is the new COO of the ZKW Group
Jun 3, 2024 07:00AM TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepa
Jun 3, 2024 07:00AM Ventra Health Appoints Erika Flowers as Chief People Officer
Jun 3, 2024 07:00AM Alzheimer's Association Encourages Americans to Take Charge of Their Brain Health
Jun 3, 2024 07:00AM IDRx Reports Updated Preliminary Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial Supporting Best-in-Class Potential for IDRX-42 in Patients with GIST
Jun 3, 2024 07:00AM redT Homes Honored as Best Individual Electric Only Builder Overall in 2023 Xcel ESNH Program
Jun 3, 2024 07:00AM Rockwell Automation to Advance Intelligent Automation, Mobile Robotics in Manufacturing Logistics in Collaboration with NVIDIA
Jun 3, 2024 07:00AM Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
Jun 3, 2024 07:00AM Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition
Jun 3, 2024 07:00AM ModernFi Announces Integration with Q2's Digital Banking Platform
Jun 3, 2024 07:00AM Pershing Square Capital Management, L.P. Announces Sale of 10% Common Equity Interest for $1.05 Billion to Strategic Investors
Jun 3, 2024 07:00AM BPGbio Appoints Biopharma Industry Leader Scott Minick to Board of Directors
Jun 3, 2024 07:00AM Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024
Jun 3, 2024 07:00AM Turing Medical Launches New Brain Mapping and Targeting Solution at ASSFN Biannual Meeting
Jun 3, 2024 07:00AM Dovenmuehle announces strategic business development promotions to support demand for its mortgage subservicing offerings
View Newer Stories View Older Stories